Portfolio comparison
Gilead Sciences Inc vs Immatics Biotechnologies
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Gilead Sciences Inc
Patents indexed
3
Year range
2013 – 2017
Most recent
2017
biotechpharmaceutical
Top Patents3 enriched
US 8592397· 2013
How Gilead Made a Stable HIV Pill Combining Two Medicines
US 9216996· 2015
Gilead's Chemical Compounds for Treating HIV Infections
US 9744181· 2017
How Gilead Stabilized the HIV Combination Pill Truvada
Activity by Decade
2010s3
Company B
Immatics Biotechnologies
Patents indexed
3
Year range
2019 – 2024
Most recent
2024
biotechpharmaceuticalimmunotherapygene_editingoncology
Top Patents3 enriched
US 10314897· 2019
How a Specific Protein Fragment Can Train Immune Cells to Fight Cancer
US 12168044· 2024
Treating Liver Cancer with Specially Trained Immune Cells
US 11542303· 2023
How a Specific Peptide Boosts the Immune System Against Cancer
Activity by Decade
2010s1
2020s2
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.